1. Home
  2. DJT vs LMAT Comparison

DJT vs LMAT Comparison

Compare DJT & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trump Media & Technology Group Corp.

DJT

Trump Media & Technology Group Corp.

SELL

Current Price

$7.98

Market Cap

2.1B

Sector

Technology

ML Signal

SELL

Logo LeMaitre Vascular Inc.

LMAT

LeMaitre Vascular Inc.

SELL

Current Price

$83.14

Market Cap

1.9B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
DJT
LMAT
Founded
2021
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.9B
IPO Year
2021
2006

Fundamental Metrics

Financial Performance
Metric
DJT
LMAT
Price
$7.98
$83.14
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
★ $107.00
AVG Volume (30 Days)
★ 2.6M
217.9K
Earning Date
11-10-2026
11-05-2026
Dividend Yield
N/A
★ 1.24%
EPS Growth
N/A
★ 30.57
EPS
N/A
★ 1.42
Revenue
$3,682,600.00
★ $249,602,000.00
Revenue This Year
N/A
$10.79
Revenue Next Year
N/A
$9.54
P/E Ratio
★ N/A
$56.90
Revenue Growth
1.76
★ 13.53
52 Week Low
$6.96
$78.22
52 Week High
$17.09
$118.01

Technical Indicators

Market Signals
Indicator
DJT
LMAT
Relative Strength Index (RSI) 32.43 56.72
Support Level $7.84 $82.58
Resistance Level $8.58 $88.54
Average True Range (ATR) 0.30 2.17
MACD -0.11 0.33
Stochastic Oscillator 2.98 96.52

Price Performance

Historical Comparison
DJT
LMAT

About DJT Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp is a media and technology company rooted in social media, digital streaming, information technology infrastructure, and more. Its initial product launch will focus on its social media platform, Truth Social, which encourages an open, free, and honest conversation without discriminating against political ideology.

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.

Share on Social Networks: